The application of Gadopentate-Dimeneglumin has no impact on progression free and overall survival as well as renal function in patients with monoclonal plasma cell disorders if general precautions are taken
Titel:
The application of Gadopentate-Dimeneglumin has no impact on progression free and overall survival as well as renal function in patients with monoclonal plasma cell disorders if general precautions are taken
Auteur:
Hillengass, J. Stoll, J. Zechmann, C. M. Kunz, C. Wagner, B. Heiss, C. Sumkauskaite, M. Moehler, T. M. Schlemmer, H. P. Goldschmidt, H. Delorme, S.